99% Purity CAS 630-93-3 Phenytoin Sodium API Phenytoin Sodium Pain Release Phenytoin Sodium

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: D-Sung phenytoin sodium
• Product Name: Phenytoin Sodium
• Name: Phenytoin Sodium Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Antiepileptic
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 630-93-3
• Mf: C15h11n2nao2
• MW: 274.255
• Melting Point: 290-299ºC
• Boiling Point: 428.2 °c at 760 Mmhg
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 500kg/Month

Product Description

99% Purity CAS 630-93-3 phenytoin sodium API phenytoin sodium Pain Release phenytoin sodium

Product Description

Product Details

Product name	Phenytoin Sodium
Appearance	White powder
Cas number	630-93-3
MF	C15H11N2NaO2
MW	274.255

Phenytoin is an antiepileptic drug which can be used in the treatment of epilepsy. The primary site of action appears to be the motor cortex where spread of seizure activity is inhibited. Possibly by promoting sodium efflux from neurons, phenytoin tends to stabilize the threshold against hyperexcitability caused by excessive stimulation or environmental changes capable of reducing membrane sodium gradient. This includes the reduction of posttetanic potentiation at synapses. Loss of posttetanic potentiation prevents cortical seizure foci from detonating adjacent cortical areas. Phenytoin reduces the maximal activity of brain stem centers responsible for the tonic phase of tonic-clonic (grand mal) seizures.

Application&Function

Function of Phenytoin sodium
Raw materials; asymmetric synthesis; plant extracts; antimalarial drugs; small molecular inhibitors; Grignard reagent; antibiotics, alkaloids; Chinese herbal ingredients; pharmaceutical intermediates

Application of Phenytoin sodium
Mainly for the treatment of complex partial seizures (temporal lobe epilepsy, psychomotor seizures), simple partial seizures (limited episodes), generalized tonic-clonic seizures and status epilepticus.

Specification